Skip to main content
BMC Infectious Diseases logoLink to BMC Infectious Diseases
. 2021 Mar 23;21:293. doi: 10.1186/s12879-021-05989-w

Relationship between neighborhood census-tract level socioeconomic status and respiratory syncytial virus-associated hospitalizations in U.S. adults, 2015–2017

Jenna E Holmen 1,, Lindsay Kim 2,3, Bryanna Cikesh 2, Pam Daily Kirley 4, Shua J Chai 2,4, Nancy M Bennett 5, Christina B Felsen 5, Patricia Ryan 6, Maya Monroe 6, Evan J Anderson 7,8,9, Kyle P Openo 8,9,10, Kathryn Como-Sabetti 11, Erica Bye 11, H Keipp Talbot 12, William Schaffner 12, Alison Muse 13, Grant R Barney 13, Michael Whitaker 2, Jennifer Ahern 14, Christopher Rowe 14,15, Gayle Langley 2, Art Reingold 14
PMCID: PMC7986301  PMID: 33757443

Abstract

Background

Respiratory syncytial virus (RSV) infection causes substantial morbidity and mortality in children and adults. Socioeconomic status (SES) is known to influence many health outcomes, but there have been few studies of the relationship between RSV-associated illness and SES, particularly in adults. Understanding this association is important in order to identify and address disparities and to prioritize resources for prevention.

Methods

Adults hospitalized with a laboratory-confirmed RSV infection were identified through population-based surveillance at multiple sites in the U.S. The incidence of RSV-associated hospitalizations was calculated by census-tract (CT) poverty and crowding, adjusted for age. Log binomial regression was used to evaluate the association between Intensive Care Unit (ICU) admission or death and CT poverty and crowding.

Results

Among the 1713 cases, RSV-associated hospitalization correlated with increased CT level poverty and crowding. The incidence rate of RSV-associated hospitalization was 2.58 (CI 2.23, 2.98) times higher in CTs with the highest as compared to the lowest percentages of individuals living below the poverty level (≥ 20 and < 5%, respectively). The incidence rate of RSV-associated hospitalization was 1.52 (CI 1.33, 1.73) times higher in CTs with the highest as compared to the lowest levels of crowding (≥5 and < 1% of households with > 1 occupant/room, respectively). Neither CT level poverty nor crowding had a correlation with ICU admission or death.

Conclusions

Poverty and crowding at CT level were associated with increased incidence of RSV-associated hospitalization, but not with more severe RSV disease. Efforts to reduce the incidence of RSV disease should consider SES.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12879-021-05989-w.

Keywords: RSV, Socioeconomic status

Key points

Higher census-tract level poverty and crowding are associated with increased incidence of RSV-associated hospitalization. Census-tract level poverty and crowding did not correlate with either ICU admission or in-hospital mortality.

Background

Respiratory syncytial virus (RSV) is an established cause of morbidity and mortality in infants and children, and its importance in adults is being increasingly recognized. In the U.S. adult population, RSV accounts for roughly 12% of medically-attended respiratory illnesses with a case fatality proportion of 6–8% in those over 50 years of age [1]. Overall, RSV infection is associated with an average of 16,272–18,444 deaths (adults and children) per year in the U.S. [2] Other data suggest that 78% of RSV-associated deaths occur in adults > 65 years of age [3]. In addition to older age being a risk factor for more severe RSV disease, adults with comorbid conditions, particularly chronic cardiopulmonary disorders, are particularly vulnerable to severe RSV-associated illness [49].

Factors related to socioeconomic status (SES) play an important role in an individual’s health and disease status [10, 11]. Evaluating the relationship between illness and SES at the census-tract level can be particularly valuable, because an individual’s health is influenced by a constellation of variables at both the individual and the neighborhood-levels [1216]. Census-tracts are small, relatively permanent geographic subdivisions that are standardized and constructed to contain approximately 4000 individuals of relatively similar population characteristics and economic status [17]. Further, working with surveillance data offers a way to examine patterns of incidence by SES, using measures not typically available for individual cases. Census-tract level poverty has been found to be one of the most sensitive and consistent metrics by which to assess the association between disease and area/neighborhood socioeconomic status [12, 14, 15].

Studies of both adults and children evaluating the incidence of influenza in relationship to census-tract level SES factors have shown a disproportionately higher incidence of influenza-associated hospitalizations in individuals living in census-tracts with higher levels of poverty and crowding [1820]. The relationship between RSV infection and SES has not been well studied, though several previous studies suggest an association between the incidence of RSV infection and lower SES [2125]. However, there have not yet been any national studies evaluating the association of RSV-associated hospitalizations and SES at the census-tract level.

In this study, data from the Centers for Disease Control and Prevention (CDC)‘s Emerging Infections Program (EIP) RSV-associated hospitalization population-based surveillance (RSV-NET) were analyzed to evaluate whether the incidence of RSV-associated hospitalizations was associated with census-tract level poverty and crowding. Further analysis evaluated whether RSV disease severity (as defined by in-hospital death or ICU admission) was associated with census-tract level poverty and crowding among those hospitalized with RSV.

Methods

Overview of surveillance system, study population, and data collection

The EIP is a network of state health departments and their collaborators in local health departments, public health laboratories, and clinical laboratories; infection control professionals; healthcare providers; and academic institutions. This network provides a national resource for infectious disease surveillance and response, conducts applied epidemiologic and laboratory research, identifies measures to prevent and control emerging infectious diseases, and strengthens national public health infrastructure [26]. RSV surveillance began during the 2016–2017 respiratory season (October 1–April 30) with retrospective surveillance for the 2014–2015 and 2015–2016 respiratory seasons in 6 states (California, Georgia, Minnesota, New York, Oregon, and Tennessee). Maryland was added in 2017–18. A case is defined as an adult ≥18 years that is a resident of the catchment area admitted ≤14 days after a laboratory-confirmed RSV test during the respiratory season to a hospital where catchment area residents receive care. Hospitalization is defined as admission to an inpatient ward of the hospital or a stay in an observation unit that is ≥24 h or a combined stay in an emergency department and observation unit for ≥24 h. Patients who are seen only in the Emergency Department or outpatient clinic (even if for more than 24 h) are not cases. Patients who are admitted to and discharged from the hospital on the same day are considered hospitalized (i.e. an overnight stay is not required). A patient was considered to have an RSV infection if RSV was detected by: rapid antigen, molecular assay, viral culture, or fluorescent antibody. Cases were identified using hospital and state public health laboratory databases, hospital infection control practitioner (ICP) databases/logs, reportable condition databases, electronic medical records (EMR), and/or review of hospital discharge records. Trained surveillance officers completed medical record abstraction using a standardized case report form.

For this analysis, cases from 33 counties in California, Georgia, Maryland, Minnesota, New York, and Tennessee were included. Oregon was excluded due to lack of geocoding data. Demographic and clinical variables collected included patient age, sex, race, ethnicity, residential street address; the presence of comorbid conditions; any substance use; and clinical course including ICU admission and in-hospital death. Participants’ addresses were geocoded using ArcGIS software.

Census data

The percentage of the population living in poverty and crowding was calculated at the census-tract level using data from the most recent five-year (2013–2017) American Community Survey (ACS). Census tracts were then divided into four levels of poverty by percentage of people living below the poverty level: 0–4.9%, 5–9.9%, 10–19.9%, and ≥ 20%. These categories were used per the recommendations of the Public Health Disparities Geocoding Project [14, 15]. Data on crowding were extracted for the relevant census tracts by the percentage of households with > 1 occupant/room. This was divided into four levels of crowding by percentage of households within a given census-tract with > 1 occupant per room as follows: low = 0–0.9%, medium low = 1–2.9%, medium high = 3–4.9%, high = ≥5%. Levels were selected as per previous studies [18, 19]. The 2010 US census was used to determine the denominator data of population of each census tract.

Statistical analysis

For calculation of incidence rates, numerators were obtained from the surveillance data by matching each patient’s geocoded address to their corresponding census-tract. Denominator data were taken from the US census 2010. Patients were divided into four age categories: 18 to < 50 years old, 50 to < 65 years old, 65 to < 80 years old, and ≥ 80 years old and age-adjusted incidence rates were calculated using these age groups and the US census 2010 data as the standard population. A Cuzick test for trend across ordered groups was conducted to compare incidence rates. Incidence rate ratios were calculated comparing each level of poverty/crowding to the lowest level of the respective category.

Log binomial regression models were used to examine the association between census-tract level poverty and crowding with severe RSV-associated illness, defined as either in-hospital death or ICU admission. First, separate unadjusted models were fit with independent variables considered to be potentially associated with severe RSV disease: age, sex, race, ethnicity, obesity as defined as body mass index (BMI) ≥30 kg/m2, smoking (current and/or former), presence of an immunocompromised condition (i.e. HIV, immunosuppressive therapy use, primary immune deficiency, graft versus host disease, solid organ transplant, bone marrow transplant, and cancer diagnosis), chronic lung disease (i.e. chronic bronchitis, chronic obstructive pulmonary disease/emphysema, asthma/reactive airway disease and cystic fibrosis), cardiovascular disease (i.e. coronary artery disease, congestive heart failure, cardiomyopathy, history of coronary artery bypass grafting, cerebral vascular accident/stroke/transient ischemic attack, atherosclerosis), and surveillance site. The medical conditions included have previously been identified as possibly being associated with an increased risk of RSV infection or severity of RSV, or other respiratory viral infection [49]. Variables that had a statistical association with death or ICU admission at a p-value < 0.2 (i.e., age, obesity, and study site) were included along with either census-tract level poverty or crowding in the multivariate model. In the final multivariate model, variables that had an association with death or ICU admission at a p-value of < 0.05 were considered statistically significant. Analyses were conducted using STATA, version 15.1.

Results

A total of 1713 cases were included in the final analysis, after excluding 45 (2.5%) with missing address information. There were more RSV-associated hospitalizations in adults older than 50 years compared with those less than 50 years of age (Table 1), and there were more women (59%) with RSV-associated hospitalizations. Among adults with an RSV-associated hospitalization, there were more individuals who identified as Black, compared to White, living in census tracts with higher percentages of poverty. Of those with insurance information available, half (50%) had more than one insurance type; the majority (57%) had Medicare insurance, a federally-funded insurance program for adults over 65 years of age and for certain qualifying individuals receiving disability benefits. The proportion of individuals with Medicaid, a federal and state insurance program for people with limited income, increased with increasing census-tract level poverty (Table 1). A total of 94% of patients had at least one comorbid condition, with pulmonary disease (51%) being the most common followed by obesity (48%) and chronic metabolic disease (46%). Smoking was the most common type of current substance use (17%) as compared to alcohol use (3%) and other drugs (3%). There was a greater percentage of current smokers (29%) in census tracts with the highest levels of poverty compared to the census tracts with the lowest levels of poverty (10%). There were 86 (5%) total in-hospital deaths among hospitalized cases. The percentage of in-hospital deaths by census-tract poverty level population (5%) was distributed evenly across each level of census-tract poverty (Table 2).

Table 1.

Demographic characteristics of adults with an RSV-associated hospitalization, 2015–2017

Demographic characteristics (1713 cases), n (%)
Percent of individuals living below the poverty level within a census tract Total (n = 1713)
Patient age (years)

0–4.9%

(n = 397)

5–9.9%

(n = 535)

10–19.9%

(n = 438)

≥20%

(n = 343)

18- < 49 49 (12) 59 (11) 70 (16) 73 (21) 251 (15)
50–64 76 (19) 132 (25) 109 (25) 115 (34) 432 (25)
65–79 137 (35) 167 (31) 123 (28) 112 (33) 539 (31)
> 80 135 (34) 177 (33) 136 (31) 43 (13) 491 (29)
Sex
 Male 180 (45) 196 (37) 183 (42) 141 (41) 700 (41)
 Female 217 (55) 339 (63) 255 (58) 202 (59) 1013 (59)
Race/Ethnicity
 White 306 (77) 358 (67) 247 (56) 123 (36) 1034 (60)
 Black 34 (9) 78 (15) 116 (26) 171 (50) 399 (23)
 Asian/Pacific Islander 33 (8) 58 (11) 38 (9) 13 (4) 142 (8)
 Other/not-reported 4 (1) 5 (1) 3 (1) 3 (1) 15 (1)
 Hispanic 15 (4) 31 (6) 25 (6) 30 (9) 101 (6)
Insurance type
 Medicare 234 (59) 321 (60) 248 (57) 176 (51) 979 (57)
 Medicaid 48 (12) 81 (15) 95 (22) 153 (45) 377 (22)
 Private insurance 229 (58) 248 (46) 188 (43) 115 (34) 780 (46)
 Uninsured 5 (1) 2 (0) 10 (2) 5 (1) 22 (1)
 Other/not-reported 11 (3) 8 (1) 9 (2) 5 (1) 33 (2)
State
 California 123 (31) 199 (37) 143 (33) 57 (17) 522 (30)
 Georgia 36 (9) 39 (7) 66 (15) 45 (13) 186 (11)
 Maryland 94 (24) 100 (19) 86 (20) 61 (18) 341 (20)
 Minnesota 43 (11) 45 (8) 28 (6) 21 (6) 137 (8)
 New York 89 (22) 101 (19) 81 (18) 124 (36) 395 (23)
 Tennessee 12 (3) 51 (10) 34 (8) 35 (10) 132 (8)

Table 2.

Clinical characteristics of adults with RSV-associated hospitalization, 2015–2017

Clinical characteristics (number of patients), n (%)
Percent of individuals living below the poverty level within a census tract Total (n = 1713)
Underlying conditions

0–4.9%

(n = 397)

5–9.9%

(n = 535)

10–19.9%

(n = 438)

≥20%

(n = 343)

Any underlying medical condition 377 (95) 508 (95) 409 (93) 321 (94) 1615 (94)
Pulmonary disease1 166 (42) 279 (52) 211 (39) 215 (63) 871 (51)
Obesity (BMI ≥30) 203 (51) 244 (46) 212 (48) 158 (46) 817 (48)
Chronic metabolic disease2 171 (43) 269 (32) 189 (35) 163 (48) 792 (46)
Cardiovascular disease3 170 (43) 245 (46) 182 (42) 156 (45) 753 (44)
Renal disease4 95 (24) 163 (30) 126 (29) 106 (31) 490 (29)
Immunocompromised5 104 (26) 136 (25) 89 (17) 93 (27) 422 (25)
Neurologic disease6 87 (22) 105 (20) 91 (17) 64 (19) 347 (20)
Liver disease7 20 (5) 29 (7) 22 (5) 30 (9) 101 (6)
Blood disorders/hemoglobinopathy8 16 (4) 17 (3) 16 (3) 10 (3) 59 (3)
Rheumatologic disease 9 18 (5) 17 (3) 15 (3) 22 (6) 72 (4)
Substance Use
 Smoker (current) 39 (10) 64 (12) 88 (20) 101 (29) 292 (17)
 Smoker (former) 153 (39) 178 (33) 131 (30) 105 (31) 567 (33)
 Smoker (no/unknown) 205 (52) 293 (55) 219 (50) 137 (40) 854 (50)
 Alcohol abuse (current) 8 (2) 11 (2) 14 (3) 25 (7) 58 (3)
 Alcohol abuse (former) 13 (3) 16 (3) 10 (2) 13 (4) 52 (3)
 Alcohol abuse (no/unknown) 376 (95) 508 (95) 414 (95) 305 (89) 1603 (94)
 Substance abuse (current) 5 (1) 8 (1) 10 (2) 28 (8) 51 (3)
 Substance abuse (former) 2 (1) 3 (1) 2 (0) 9 (3) 16 (1)
 Substance abuse (no/unknown) 390 (98) 524 (98) 426 (98) 306 (89) 1646 (96)
Indicators of Severe Illness
 Hospital stay > 7 days 103 (26) 110 (21) 106 (24) 103 (30) 422 (25)
 ICU admission 86 (22) 92 (17) 86 (20) 80 (23) 344 (20)
 Need for mechanical ventilation 32 (8) 39 (7) 35 (8) 37 (11) 143 (8)
 Death 19 (5) 28 (5) 21 (5) 18 (5) 86 (5)

1asthma, COPD, chronic bronchitis, emphysema, CF, Chronic respiratory failure, active TB, other

2diabetes, thyroid disease, other endocrinopathy

3coronary artery disease, congestive heart failure, cardiomyopathy, prior coronary artery bypass graft, cerebral vascular accident/stroke/transient ischemic attack, atherosclerosis

4chronic kidney disease, end-stage renal disease, glomerulonephritis, nephrotic syndrome, other

5cancer, complement deficiency, HIV, AIDS, immunoglobulin deficiency, any immunosuppressive therapy, status-post solid organ transplant, s/p bone marrow transplant, receipt of steroid therapy, other

6cerebral palsy, cognitive dysfunction, dementia, developmental delay, Trisomy 21, paralysis, seizures, muscular dystrophy, multiple sclerosis, myasthenia gravis, other

7cirrhosis, hepatitis B or C, other

8aplastic anemia, Sickle cell disease, asplenia, other

9lupus, Juvenile idiopathic arthritis, rheumatoid arthritis, psoriasis, polymyositis, polymyalgia, polyarteritis nodosa, vasculitis, other

The incidence of RSV-associated hospitalizations of adults increased with higher levels of census-tract poverty (Fig. 1), with a statistically significant test for trend (p < 0.005). In census tracts with the highest percentages of individuals living in poverty, the rate of RSV-associated hospitalizations was 2.58 (CI 2.23–2.98) times the rate among those living in census tracts with the lowest percentage of individuals living in poverty (Table 3). The incidence of RSV-associated hospitalizations among adults increased with higher levels of census-tract level crowding (Fig. 2), with a statistically significant test for trend (p < 0.005). The rate of RSV-associated hospitalization among individuals living in neighborhoods with the highest percentages of crowding was 1.52 (CI 1.33–1.73) times higher than that in individuals living in neighborhoods with the lowest levels of crowding (Table 4).

Fig. 1.

Fig. 1

Age-adjusted incidence rate of RSV-associated hospitalizations of adults by census-tract poverty level, 2015–2017. Test for trend p-value: < 0.005

Table 3.

Incidence rate ratios for RSV-associated hospitalizations of adults by census-tract poverty level, 2015–2017

Poverty levels (all sites) Incidence rate ratio 95% Confidence Interval
0–4.9%
5–9.9% 1.12 0.98, 1.28
10–19.9% 1.38 1.20, 1.58
≥20% 2.58 2.23, 2.98

Fig. 2.

Fig. 2

Age-adjusted incidence rate of RSV-associated hospitalization in adults by census-tract crowding, 2015–2017. Test for trend p-value: < 0.005

Table 4.

Incidence rate ratios for RSV-associated hospitalization in adults by census-tract crowding, 2015–2017

Neighborhood crowding Incidence rate ratio 95% Confidence Interval
Low
Medium low 1.14 1.01–1.28
Medium high 1.14 0.98–1.33
High 1.52 1.33, 1.73

Neither census-tract level poverty nor crowding had an association with either ICU admission or death in either bivariate or multivariate analysis (See Additional Files 1 and 2).

Discussion

In this study, higher census-tract level poverty was associated with a higher incidence of RSV-associated hospitalization in adults. This association is likely multifactorial, with poverty unlikely being the sole explanatory component. Higher census-tract crowding was also associated with a higher incidence of RSV-associated hospitalizations, particularly when comparing neighborhoods with the lowest levels of crowding with neighborhoods with the highest levels of crowding.

This study was conducted using census-tract level data because individual metrics of SES are limited in surveillance data and because neighborhood-level variables have an impact on a person’s health, including healthcare-related variables such as access to care; infrastructure variables, such as sanitation, neighborhood density, and access to resources; and environmental variables, such as pollution [27]. All of these variables can be associated with SES and affect a person’s health and are best studied on the census-tract level [1214]. Furthermore, among census-tract variables associated with SES, census-tract level poverty has been shown to be the most sensitive and consistent metric by which to assess the association between disease and SES [12, 14, 15]. The finding of increasing incidence of RSV-associated hospitalization among individuals living in census-tracts with increasing percentages of residents living below poverty most likely reflects the sum of the negative health impacts of social determinants of health associated with living in impoverished communities.

The influence of poverty on RSV incidence and severity in adults living in low income countries is likely to be even more pronounced. While data on RSV incidence is limited in adults, studies looking at RSV lower respiratory tract disease in children have shown an incidence of RSV-associated lower respiratory tract disease over two times higher in developing as compared to industrialized countries, as well as an RSV-associated case fatality ratio 3–7 times higher in developing as compared to industrialized countries [28]. In low income countries where there is less access to medical care and other resources, the association between poverty and RSV incidence and mortality is likely to be more robust in both children and adults.

These results are consistent with those of other studies comparing disease incidence among the highest and lowest categories of census-tract level poverty, as well as census tract-level crowding [14, 15]. Interestingly, incident rates were higher in census-tracts with high levels of poverty than in census tracts with high levels of crowding, which is different from the findings of prior studies that have found the opposite pattern [14, 15]. These prior studies examined the incidence of other diseases, including sexually transmitted infections (STIs) and tuberculosis (TB) [14, 15]. RSV infection differs from STI and TB in that a prior infection with RSV can provide partial immunity [2931]. Prior studies have shown that the risk of RSV infection is inversely related to the level of neutralizing antibodies and that repeat infections with RSV tend to be more mild [32, 33]. It is plausible that individuals living in more crowded neighborhoods have frequent and repeated infections with RSV and thus may be partially protected from disease severe enough to warrant hospitalization. This partial protection from severe disease may explain why census-tract level crowding was a less robust marker of disparities related to RSV-associated hospitalization as opposed to census-tract level poverty.

The findings in this study are similar to those from prior studies of influenza. Studies of influenza using census-tract data have shown an increasing incidence of adults with influenza-associated hospitalization corresponding to increasing census-tract level poverty, as well as with census-tract level crowding [18]. Similar to these findings, studies of influenza have also failed to find an association between severe disease, defined as death or ICU admission, and census-tract level poverty [34].

Recognizing and eliminating health disparities is an important goal of the CDC’s Healthy People 2020 [10, 11]. Identifying and quantifying health disparities is essential to establish a baseline measure from which to evaluate the impact of future interventions aimed at eliminating these disparities. Understanding SES-related disparities associated with RSV infection is critical, given that there are promising vaccines on the horizon [35]. There are currently a number of RSV vaccines in development, including several targeting the elderly, that are in phase 2 and 3 trials [35]. It is important to understand the epidemiologic features of RSV disease to provide a baseline against which to measure the impact of future intervention efforts on health disparities and to guide future vaccine recommendations.

This study was limited by its inclusion of only hospitalized, laboratory-confirmed cases. Cases are thus not reflective of the overall burden of RSV disease, which is most commonly managed on an outpatient basis [36, 37]. Furthermore, identification of RSV-associated hospitalized cases through RSV-NET is dependent on clinician testing; limited numbers of patients undergo RSV testing, even among the subset of patients who are admitted to the hospital [38]. There can also be biases in the decision to admit patients and to test for RSV both within and between different institutions that could have influenced the results. Because only in-hospital deaths are captured, our severity analysis may have been influenced by the higher hospitalization rate among individuals living in higher poverty as we don’t know how many individuals from lower poverty census-tracts may have died outside the hospital.

Conclusions

In conclusion, an association was found between the incidence of RSV-associated hospitalizations in adults and higher census tract-level poverty and crowding, although no relationship was observed between severity as measured by ICU admission and in-hospital mortality with census-tract level poverty or crowding. Future efforts to decrease the burden of RSV disease, including vaccination, should address these disparities. This paper provides a baseline of the incidence of RSV-associated hospitalizations in adults by census-tract SES, by which the impact on these SES disparities of future efforts to decrease the burden of RSV disease can be measured.

Supplementary Information

12879_2021_5989_MOESM1_ESM.docx (32.7KB, docx)

Additional file 1. Bivariate association of demographic and clinical characteristics with severe RSV disease (death or ICU admission) among patients hospitalized with RSV.

12879_2021_5989_MOESM2_ESM.docx (33.4KB, docx)

Additional file 2. Multivariate analysis of odds of severe RSV disease (death or ICU admission) among adults with RSV-associated hospitalization by poverty category, adjusted for age, obesity, and study site. (Data from Tennessee and Georgia were collinear, so data from Tennessee were omitted)

Acknowledgements

The authors would like to acknowledge the work of Ruth Lynfield, Richard Danila, Austin Bell, Deborah Godine, Linda Frank, Emily Fawcett, Andrew Martin, Robert Sunkel, David Blythe, Eva Pradhan, Kerianne Engesser, Nancy Spina, RaeAnne Kurtz, Tiffanie Markus, Karen Leib, Katie Dyer, Terri McMinn, Danielle Ndi, Kathy Billings, and John Ujwok in the preparation of this manuscript.

Abbreviations

RSV

Respiratory Syncytial Virus

SES

Socioeconomic Status

CT

census-tract

ICU

Intensive Care Unit

CDC

Centers for Disease Control and Prevention

EIP

Emerging Infections Program

ACS

American Community Survey

STI

Sexually transmitted infection

TB

Tuberculosis

Authors’ contributions

JEH helped design the study and analyzed and interpreted the data and composed the manuscript. LK, GL, and AR were major contributors in the design of the study and composition of the manuscript. BC and MW compiled and organized the data. PDK, SJC, NMB, CBF, PR, MM, EJA, KPO, KCS, EB, HKT, WS, AM, and GRB collected the data. JA and CR had significant contributions in study design and analysis. All authors read and approved the final manuscript.

Funding

Data collection for this work was supported by the Centers for Disease Control and Prevention through an Emerging Infections Program cooperative agreement (grant CL17–701).

Availability of data and materials

The data that support the findings of this study are available from the CDC but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the CDC.

Declarations

Ethics approval and consent to participate

This study was exempted from IRB review at CDC due to being public-health non-research surveillance data and thus no consent is needed. All data were completely deidentified. All the methods were carried out in accordance with relevant guidelines and regulations.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Colosia AD, Yang J, Hillson E, Mauskopf J, Copley-Merriman C, Shinde V, Stoddard J. The epidemiology of medically attended respiratory syncytial virus in older adults in the United States: a systematic review. PLoS One. 2017;12(8):e0182321. doi: 10.1371/journal.pone.0182321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179–186. doi: 10.1001/jama.289.2.179. [DOI] [PubMed] [Google Scholar]
  • 3.Collins PL, Melero JA. Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res. 2011;162(1–2):80–99. doi: 10.1016/j.virusres.2011.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Falsey AR, Hennessey PA, Formica MA, Cox C, Walsh EE. Respiratory syncytial virus infection in elderly and high-risk adults. N Engl J Med. 2005;352(17):1749–1759. doi: 10.1056/NEJMoa043951. [DOI] [PubMed] [Google Scholar]
  • 5.Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis. 2004;189(2):233–238. doi: 10.1086/380907. [DOI] [PubMed] [Google Scholar]
  • 6.Ackerson B, Tseng HF, Sy LS, Solano Z, Slezak J, Luo Y, Fischetti CA, Shinde V. Severe morbidity and mortality associated with respiratory syncytial virus versus influenza infection in hospitalized older adults. Clin Infect Dis. 2019;69(2):197–203. doi: 10.1093/cid/ciy991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Duncan CB, Walsh EE, Peterson DR, Lee FE, Falsey AR. Risk factors for respiratory failure associated with respiratory syncytial virus infection in adults. J Infect Dis. 2009;200(8):1242–1246. doi: 10.1086/605948. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Falsey AR, McElhaney JE, Beran J, et al. Respiratory syncytial virus and other respiratory viral infections in older adults with moderate to severe influenza-like illness. J Infect Dis. 2014;209(12):1873–1881. doi: 10.1093/infdis/jit839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK. Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. J Infect Dis. 2012;206(1):56–62. doi: 10.1093/infdis/jis309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Koh HK, Blakey CR, Roper AY. Healthy people 2020: a report card on the health of the nation. JAMA. 2014;311(24):2475–2476. doi: 10.1001/jama.2014.6446. [DOI] [PubMed] [Google Scholar]
  • 11.Centers for Disease Control. Healthy People 2020.
  • 12.Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Painting a truer picture of US socioeconomic and racial/ethnic health inequalities: the public health disparities geocoding project. Am J Public Health. 2005;95(2):312–323. doi: 10.2105/AJPH.2003.032482. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Krieger N. Theories for social epidemiology in the 21st century: an ecosocial perspective. Int J Epidemiol. 2001;30(4):668–677. doi: 10.1093/ije/30.4.668. [DOI] [PubMed] [Google Scholar]
  • 14.Krieger N, Chen JT, Waterman PD, Rehkopf DH, Subramanian SV. Race/ethnicity, gender, and monitoring socioeconomic gradients in health: a comparison of area-based socioeconomic measures--the public health disparities geocoding project. Am J Public Health. 2003;93(10):1655–1671. doi: 10.2105/AJPH.93.10.1655. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Krieger N, Waterman PD, Chen JT, Soobader MJ, Subramanian SV. Monitoring socioeconomic inequalities in sexually transmitted infections, tuberculosis, and violence: geocoding and choice of area-based socioeconomic measures--the public health disparities geocoding project (US) Public Health Rep. 2003;118(3):240–260. doi: 10.1093/phr/118.3.240. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chen FM, Breiman RF, Farley M, Plikaytis B, Deaver K, Cetron MS. Geocoding and linking data from population-based surveillance and the US census to evaluate the impact of median household income on the epidemiology of invasive Streptococcus pneumoniae infections. Am J Epidemiol. 1998;148(12):1212–1218. doi: 10.1093/oxfordjournals.aje.a009611. [DOI] [PubMed] [Google Scholar]
  • 17.Harvard School of Public Health. The public health disparities geocoding project monograph.
  • 18.Tam K, Yousey-Hindes K, Hadler JL. Influenza-related hospitalization of adults associated with low census tract socioeconomic status and female sex in New Haven County, Connecticut, 2007-2011. Influenza Other Respir Viruses. 2014;8(3):274–281. doi: 10.1111/irv.12231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Yousey-Hindes KM, Hadler JL. Neighborhood socioeconomic status and influenza hospitalizations among children: New Haven County, Connecticut, 2003-2010. Am J Public Health. 2011;101(9):1785–1789. doi: 10.2105/AJPH.2011.300224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Chandrasekhar R, Sloan C, Mitchel E, Ndi D, Alden N, Thomas A, Bennett NM, Kirley PD, Hill M, Anderson EJ, Lynfield R, Yousey-Hindes K, Bargsten M, Zansky SM, Lung K, Schroeder M, Monroe M, Eckel S, Markus TM, Cummings CN, Garg S, Schaffner W, Lindegren ML. Social determinants of influenza hospitalization in the United States. Influenza Other Respir Viruses. 2017;11(6):479–488. doi: 10.1111/irv.12483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Beamer PI, Lothrop N, Lu Z, Ascher R, Ernst K, Stern DA, Billheimer D, Wright AL, Martinez FD. Spatial clusters of child lower respiratory illnesses associated with community-level risk factors. Pediatr Pulmonol. 2016;51(6):633–642. doi: 10.1002/ppul.23332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Jansson L, Nilsson P, Olsson M. Socioeconomic environmental factors and hospitalization for acute bronchiolitis during infancy. Acta Paediatr. 2002;91(3):335–338. doi: 10.1111/j.1651-2227.2002.tb01725.x. [DOI] [PubMed] [Google Scholar]
  • 23.Franklin JA, Anderson EJ, Wu X, Ambrose CS, Simoes EA. Insurance Status and the Risk of Severe Respiratory Syncytial Virus Disease in United States Preterm Infants Born at 32–35 Weeks Gestational Age. Open Forum Infect Dis. 2016;3(3):ofw163. [DOI] [PMC free article] [PubMed]
  • 24.Sangare L, Curtis MP, Ahmad S. Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography. J Pediatr. 2006;149(3):373–377. doi: 10.1016/j.jpeds.2006.04.063. [DOI] [PubMed] [Google Scholar]
  • 25.Iwane MK, Chaves SS, Szilagyi PG, Edwards KM, Hall CB, Staat MA, Brown CJ, Griffin MR, Weinberg GA, Poehling KA, Prill MM, Williams JV, Bridges CB. Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol. 2013;177(7):656–665. doi: 10.1093/aje/kws299. [DOI] [PubMed] [Google Scholar]
  • 26.Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9(7):781–787. doi: 10.3201/eid0907.030083. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Chen E. Why socioeconomic status affects the health of children. A Psychosocial Perspective Am Psychol Soc. 2004;13(3):112–5.
  • 28.Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O'Brien KL, Roca A, Wright PF, Bruce N, Chandran A, Theodoratou E, Sutanto A, Sedyaningsih ER, Ngama M, Munywoki PK, Kartasasmita C, Simões EAF, Rudan I, Weber MW, Campbell H. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–1555. doi: 10.1016/S0140-6736(10)60206-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Falsey AR, Singh HK, Walsh EE. Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol. 2006;78(11):1493–1497. doi: 10.1002/jmv.20724. [DOI] [PubMed] [Google Scholar]
  • 30.Openshaw PJ, Chiu C. Protective and dysregulated T cell immunity in RSV infection. Curr Opin Virol. 2013;3(4):468–474. doi: 10.1016/j.coviro.2013.05.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Yamaji Y, Yasui Y, Nakayama T. Development of acquired immunity following repeated respiratory syncytial virus infections in cotton rats. PLoS One. 2016;11(5):e0155777. doi: 10.1371/journal.pone.0155777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Glezen WP, Taber LH, Frank AL, Kasel JA. Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986;140(6):543–546. doi: 10.1001/archpedi.1986.02140200053026. [DOI] [PubMed] [Google Scholar]
  • 33.Stensballe LG, Ravn H, Kristensen K, Meakins T, Aaby P, Simoes EA. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus. J Pediatr. 2009;154(2):296–298. doi: 10.1016/j.jpeds.2008.07.053. [DOI] [PubMed] [Google Scholar]
  • 34.Stewart-Schicker R, Yousey-Hindes K, Rolfes M, et al. Neighborhood-level poverty, poverty-associated factors, and severe outcomes among adults hospitalized with influenza—United States, 2012–2015. Open Forum Infect Dis. 2017;4(suppl_1):S569. doi: 10.1093/ofid/ofx163.1487. [DOI] [Google Scholar]
  • 35.PATH. vaccine library. RSV vaccine and mAb snapshot.
  • 36.Pastula ST, Hackett J, Coalson J, et al. Hospitalizations for Respiratory Syncytial Virus Among Adults in the United States, 1997–2012. Open Forum Infect Dis. 2017;4(1):ofw270. doi: 10.1093/ofid/ofw270. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Pisesky A, Benchimol EI, Wong CA, Hui C, Crowe M, Belair MA, Pojsupap S, Karnauchow T, O'Hearn K, Yasseen AS, McNally JD. Incidence of hospitalization for respiratory syncytial virus infection amongst children in Ontario, Canada: a population-based study using validated health administrative data. PLoS One. 2016;11(3):e0150416. doi: 10.1371/journal.pone.0150416. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Lee N, Walsh EE, Sander I, Stolper R, Zakar J, Wyffels V, Myers D, Fleischhackl R. Delayed diagnosis of respiratory syncytial virus infections in hospitalized adults: individual patient data, record review analysis and physician survey in the United States. J Infect Dis. 2019;220(6):969–979. doi: 10.1093/infdis/jiz236. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

12879_2021_5989_MOESM1_ESM.docx (32.7KB, docx)

Additional file 1. Bivariate association of demographic and clinical characteristics with severe RSV disease (death or ICU admission) among patients hospitalized with RSV.

12879_2021_5989_MOESM2_ESM.docx (33.4KB, docx)

Additional file 2. Multivariate analysis of odds of severe RSV disease (death or ICU admission) among adults with RSV-associated hospitalization by poverty category, adjusted for age, obesity, and study site. (Data from Tennessee and Georgia were collinear, so data from Tennessee were omitted)

Data Availability Statement

The data that support the findings of this study are available from the CDC but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of the CDC.


Articles from BMC Infectious Diseases are provided here courtesy of BMC

RESOURCES